Skip to main content
Clinical Trials/NCT00226018
NCT00226018
Completed
Phase 4

Performance of Acceleromyography With and Without Preload During Neuromuscular Blockade

Rigshospitalet, Denmark1 site in 1 country60 target enrollmentMarch 2005

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Neuromuscular Blockade
Sponsor
Rigshospitalet, Denmark
Enrollment
60
Locations
1
Primary Endpoint
The precision of acceleromyography with and without preload during recovery
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

The purpose of this study is to examine the precision, bias and limits of agreement when monitoring the neuromuscular block with acceleromyography with and without preload and compare the method to the gold standard, mechanomyography.

Registry
clinicaltrials.gov
Start Date
March 2005
End Date
October 2006
Last Updated
18 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA I-III
  • General anesthesia \> 1 hour
  • Surgery under supine position with possibility of monitoring the neuromuscular block in both arms (thumbs)
  • Written informed content

Exclusion Criteria

  • Neuromuscular disorders, hepatic and renal dysfunction
  • Medication expected to interfere with the neuromuscular blocking agent
  • Allergy to any medication used during anesthesia
  • Body weight less or exceeding 20% of the ideal body weight
  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

The precision of acceleromyography with and without preload during recovery

Secondary Outcomes

  • Bias and limits of agreement for acceleromyography (AMG) with and without preload compared to mechanomyography (MMG) during recovery
  • All the following outcomes obtained with AMG with and without preload are compared to MMG. Furthermore the responses are compared when the AMG-values are "normalized":
  • Bias og limits of agreement between control TOF
  • Onset time
  • Time to reappearance of T1, T2, T3 and T4
  • Twitch height of T1 at reappearance of T1, T2, T3 and T4
  • Time to T1=25%
  • Interval 25-75%
  • Time to TOF-ratio = 0.9 and 1.0
  • Time to final T1
  • Time to final TOF ratio

Study Sites (1)

Loading locations...

Similar Trials